Global BioAccess Fund
Venture capital fund investing in venture-stage biopharma and medical device companies developing transformative therapeutics for serious unmet medical needs.
Global BioAccess Fund was founded in 2021, is headquartered in New York, United States, has 3 recorded investments, and includes 3 companies in its recorded portfolio.
- Headquarters
- New York, United States
- Founded
- 2021
- Website
- rmglobal.com
- Portfolio Companies
- 3
- Total Investments
- 3
- Last Investment
- Jan 2026
- Geographic Focus
- Europe, North America
Indexed holds 3 portfolio companies and 3 funding rounds for this investor. The full record is or through the API.
Investment Thesis
Global BioAccess Fund is a Venture Capital firm based in New York, United States. It was founded in 2021. It has made 3 investments, including Alveus Therapeutics, Acesion Pharma and ShiraTronics. Focus areas include Biotech and Healthcare.
Portfolio3
Co-investors22
Sign up to view co-investors
22 co-investors across 24 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×18 · Corporate VC ×2 · Private Equity ×2 · 16 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/global-bioaccess-fund"><img src="https://indexed.vc/api/badge/investor/global-bioaccess-fund" alt="Global BioAccess Fund on Indexed.vc" width="260" height="76" /></a>